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Urethral Reconstruction of Critical Defects
in Rabbits Using Molecularly Defined
Tubular Type I Collagen Biomatrices:
Key Issues in Growth Factor Addition
Jody E. Nuininga, M.D.,1,* Martin J.W. Koens, M.Sc.,2,* Dorien M. Tiemessen, B.Sc.,1
Egbert Oosterwijk, Ph.D.,1 Willeke F. Daamen, Ph.D.,2 Paul J. Geutjes, M.Sc.,1
Toin H. van Kuppevelt, Ph.D.,2 and Wout F.J. Feitz, M.D., Ph.D.1
Tubular type I collagen biomatrices with and without growth factors (GFs) were constructed and evaluated in a
rabbit model for critical urethral defects. Porous tubular biomatrices with an inner diameter of 3mm were
prepared using highly purified collagen fibrils and were crosslinked with or without heparin. Heparinized
biomatrices were supplemented with the heparin-binding GFs vascular endothelial GF, fibroblast GF-2, and
heparin-binding epidermal GF. Biomatrices with and without GFs were used to replace a critical 1 cm urethral
segment in rabbits (n¼ 32). All animals showed normal urination without urinary retention. General histology
and immunohistology of graft areas (2, 4, 12, and 24 weeks after implantation) indicated that all biomatrices
were replaced by urethra-like structures with normal appearing cytokeratin-positive urothelium surrounded by
vascularized tissue. The GF-containing biomatrices showed an increase in extracellular matrix deposition,
neovascularization, urothelium, glands, granulocytes, and fibroblasts, compared with biomatrices without GF.
GFs substantially improved molecular features of healing but failed to be superior in functional outcome.
Retrograde urethrography indicated a normal urethral caliber in case of biomatrices without GF, but a relative
narrowing of the urethra at 2 weeks postsurgery and diverticula after 4 weeks in case of biomatrices with GF. In
conclusion, tubular acellular type I collagen biomatrices were successful in repairing urethral lesions in artificial
urethral defects, and inclusion of GF has a profound effect on regenerative processes.
Introduction
Repair of severe hypospadias is often associated withmultiple clinical interventional procedures and grafting.
Current grafting techniques include the use of donor tissues
such as preputial skin or buccal mucosa. In most instances,
the initial results are satisfactory. But long-term follow-up
studies show unsatisfactory results and complications, as
fistula formations, recurrent strictures, and necrosis can oc-
cur in up to 54% of patients.1,2 Additionally, the amount of
donor tissue or tissue that is suitable for grafting can be a
limiting factor. These issues may be relieved by tissue engi-
neering strategies for urethral reconstruction. However,
the development of an optimal biomaterial for urethral re-
construction remains a significant challenge and suitable
constructs are currently not available in clinical practice.
Biocompatible and biodegradable biomatrices have already
been successfully applied for urethral repair, mostly as an
onlay.3–5 In studies with tubular biomatrices, cellular seeding
of the scaffold was an absolute requirement to achieve suc-
cessful repair of the defect.6–9 These findings appear to
suggest that the use of acellular matrices for urethral recon-
struction is limited. Previously, we tubularized small intes-
tinal submucosa (SIS) (COOK) and molecularly defined
biomatrices by suturing and compared the regenerative ca-
pacity in a rabbit urethral defect model. We reported
equating results between these two scaffolds without no-
ticeable complications.4 Construction of pretubularized type
I collagen biomatrices and their supplementation with
growth factors (GFs) may facilitate the surgical procedure
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and improve cellular ingrowth, respectively. For urethral
regeneration, multiple GFs are involved because different
cell populations are needed to restore the reconstructed site.
Epidermal GF (EGF) is known to play a key role in urothelial
regeneration,10 whereas fibroblast GF-2 (FGF-2) and vascular
endothelial GF (VEGF) are involved in angiogenesis and
blood vessel maturation.11 As all three GFs bind to heparin,
we developed a tubular collagenous biomatrix containing
heparin and supplemented this with heparin-binding EGF
(HB-EGF), VEGF, and FGF-2. Biomatrices with and without
heparin and GFs were used to replace rabbit urethra and
were evaluated using retrograde urethrography and immu-
nohistochemical examination.
Materials and Methods
Unless stated otherwise, all chemicals were purchased
from Merck.
Preparation of tubular collagen biomatrices
For the construction of tubular biomatrices, insoluble
type I collagen fibrils were purified from pulverized bovine
Achilles tendon as previously described.12 A 0.67wt% type I
collagen suspension in 0.25M acetic acid was prepared and
incubated for 16 h at 48C. Then the suspension was homog-
enized, deaerated by centrifugation at 250 g for 15min,
and poured into polystyrene tubular moulds (all at 48C).
Stainless-steel mandrels (diameter 3mm) and spacers were
placed. The molds were frozen at 208C for 4 h followed by
lyophilization (Fig. 1A). The tubular collagen biomatrices
were crosslinked with 1-ethyl-3-(3-dimethyl aminopropyl)
carbodiimide (Fluka) and N-hydroxysuccinimide (Fluka).13,14
In brief, tubular biomatrices were incubated at a content of
0.4mg collagen/mL in 50mM 2-morpholinoethane sulphonic
acid (USB Corporation) containing 40% (v/v) ethanol, 33mM
1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide, and 6mM
N-hydroxysuccinimide (pH 5.0), with or without 0.25% (w/v)
heparin (Diosynth) for 4 h while shaking at 218C. Biomatrices
were washed with 0.1M Na2HPO4, 1M and 2M NaCl, and
demineralized water. Biomatrices were disinfected by 70%
(v/v) ethanol washings and subsequently stored at 208C.
Before implantation, scaffolds were washed extensively with
sterile phosphate-buffered saline (PBS, pH 7.4) under sterile
conditions.
For correct GF supplementation, simultaneous incubation
(3.5 mg/mL per GF), proportional incubation (5.5 mg FGF-2/
mL, 3.5 mg VEGF/mL, 1.5 mg HB-EGF/mL), and preincuba-
tion of FGF-2 were investigated. In the latter case, disinfected
heparinized biomatrices (4mg matrix/mL) were incubated
in sterile PBS containing 3.5 mg/mL human recombinant
FGF-2 (R&D) for 1 h at 218C. Next, human recombinant
VEGF (R&D) and human recombinant HB-EGF (R&D) were
added (final concentration of 3.5 mg/mL PBS per GF) and
incubated for 16 h at 218C. Subsequently, supplemented
FIG. 1. Overview of the construction, implantation, and explantation of tubular type I collagen matrices. Scheme of the
tubular molding process (A), a cross-sectional scanning electron microscopical image of part of a crosslinked tubular matrix
(B, bar represents 100 mm), surgical replacement by a tubular matrix (arrow) of a 1 cm urethral defect (C), and explant at 24
weeks (D). L: lumen. Color images available online at www.liebertonline.com/ten.
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biomatrices were washed three times (each 15min) with
sterile PBS and used immediately.
Biochemical characterization of tubular
collagen matrices
The degree of collagen crosslinking was determined by a
trinitrobenzosulfonic acid assay.12,15 The amount of bound
heparin to the biomatrices was measured by hexosamine
analysis.12 The bound GFs was determined using Western
blot analysis.11,16 In short, biomatrix samples were run on
sodium dodecyl sulfate–polyacrylamide gels, together with a
series of known amounts of VEGF, FGF-2, and HB-EGF.
Subsequently, gels were blotted, blocked using 1% bovine
serum albumin (PAA), and incubated with either rabbit-anti-
bovine FGF-2 (1: 8000; Sigma-Aldrich), goat-anti-human HB-
EGF (1:1000; R&D), or goat-anti-rabbit VEGF (1:400; R&D)
containing 1% bovine serum albumin. After washing, blots
were incubated with the appropriate secondary antibodies
conjugated to horseradish peroxidase and washed. Perox-
idase activity was detected by chemiluminescence using
ECL Western Blotting Detection Reagents (GE Healthcare)
followed by detection and digital quantification (Adobe
Photoshop CS3).
Scanning electron microscopy
Scanning electron microscopy was performed to analyze
the morphology of the biomatrices. The samples were fixed
on a stub with double-sided carbon tape. Next, the samples
were sputtered with an ultrathin gold layer and examined in
a JEOL Scanning Electron Microscope 6310 at an accelerating
voltage of 15 kV.
Animals
The animal experiment was approved by the Animal
Ethics Committee of the Radboud University Nijmegen
Medical Centre, Nijmegen, The Netherlands. A total of 32
male New Zealand white rabbits (2.5–3.5 kg) were housed
individually in a temperature-controlled cage with 50%–55%
humidity for a 12 h light–dark cycle with free access to
standard laboratory chow and tap water. After a minimum
of 2-week quarantine period, the rabbits were fasted over-
night prior to surgery. No antibiotic prophylaxis was given.
Animals received fentanyl-fluanisone (0.5mL/kg intramus-
cularly) before induction of anesthesia.
Surgical procedure for urethra replacement
The surgical procedures have been described in detail
elsewhere.4 In short, rabbits were placed on the operating
table in the supine position and general anesthesia was
achieved with 2% isofluorane by endotracheal intubation
with spontaneous ventilation. Blood pressure, heart rate, and
hemoglobin oxygen saturation were monitored continuously
throughout the period of anesthesia. After shaving and
washing of the ventral penis, the urogenital region was
disinfected with povidone-iodine scrub. Next, a transurethral
8F catheter was placed in situ. Urethrography was performed
preoperatively. Under a 2.5 optical magnification, a complete
resection of a urethral segment of 1 cm in length was made at
*1.5 cm below the distal urethral meatus with the penis in
stretch. A tubular biomatrix of 1 cm (diameter 3mm) was
placed and secured with eight notched sutures (70 vicryl;
Ethicon). Two nonresolvable sutures (60 prolene; Ethicon)
were placed at the external ends of the tubular biomatrix for
future reference. The subcutis and skin were closed in two
layers with 70 vicryl suture. The transurethral catheter was
removed directly after surgery.
Explantation schedule
All rabbits were euthanized with an overdose of pento-
barbital. Then, urethrography and collection of the urethra
was performed. The total penis was removed, fixed in 4%
(v/v) formalin in PBS for 24 h, and embedded in paraffin.
The rabbits were divided into two groups: a crosslinked
collagen biomatrix group (COLX) and a group that received
heparinized tubular biomatrices supplemented with VEGF,
FGF-2, and HB-EGF (COLX-Hep-GF). Four rabbits were
sacrificed in each group at 2, 4, 12, and 24 weeks after im-
plantation (n¼ 32).
Immunohistological examination
Macroscopic inspection and evaluation of the urethra was
performed. For histological examination, two samples of
every group were cut into four equal transversal pieces. The
other two samples were processed longitudinally. Then,
sections were cut (4mm) and stained with hematoxylin and
eosin. Sections were scored independently by two panels of
two investigators ( J.N. and P.G., and M.K. and W.D.)
for cellular infiltration, neovascularization, new extracellu-
lar matrix (ECM) formation, urothelium, and biomatrix
Table 1. Biochemical Characteristics of Biomatrices
Tubular
scaffolds
Crosslinked
using
EDC/NHS
Amine group content
(nmol/mg biomatrix)
n¼ 3 (mean s.d.)
Heparin content
(mg/mg biomatrix)
n¼ 3 (mean s.d.)
VEGF content
(ng/mg biomatrix)
n¼ 4 (mean s.d.)
FGF-2 content
(ng/mg biomatrix)
n¼ 4 (mean s.d.)
HB-EGF content
(ng/mg biomatrix)
n¼ 4 (mean s.d.)
COL No 306 16 0a — — —
COLX Yes 189 10 — — — —
COLX-Hep-GF Yes 135 4 178 15 116 63 104 6 162 27
The amounts of amine groups (indicative for crosslinking), heparin, and various growth factors are given. COL were used as reference.
aSet to 0.
EDC, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide; NHS, N-hydroxysuccinimide; s.d., standard deviation; VEGF, vascular endothelial
growth factor; FGF-2, fibroblast growth factor-2; HB-EGF, heparin-binding epidermal growth factor; COL, noncrosslinked collagen
biomatrices; COLX, crosslinked collagen biomatrices; COLX-Hep-GF, heparinized collagen biomatrices supplemented with growth factors;
—, not determined.
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FIG. 2. Retrograde urethro-
grams. The urethrograms of the
COLX group showed normal
caliber of the urethra at 2, 4, 12,
and 24 weeks after implantation
(A, C, E, G). In the COLX-Hep-GF
group (B, D, F, H), rabbits had
relative narrowing of the urethra
at 2 weeks and diverticula after
4 weeks. Arrows indicate the
position of the biomatrix. COLX,
crosslinked collagen biomatrix;
COLX-Hep-GF, heparinized
collagen biomatrices supple-
mented with growth factors.
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remnants. In case of dissimilar scores, slides were re-
evaluated until agreement was reached.
Immunohistochemistry was performed for CD31, pancy-
tokeratin, desmin, and smooth muscle actin. In brief, paraffin
sections were deparaffinized in xylene and hydrated in a
degrading series of ethanol. After blocking of endogenous
peroxidase activity, sections were incubated with monoclo-
nal mouse anti-human CD31 (1:20; Dako), monoclonal
mouse anti-human cytokeratin (1:800; LabVision), monoclo-
nal mouse anti-human desmin (1:200; Biogenex), or mono-
clonal mouse anti-human smooth muscle actin (1:15,000;
Sigma). After PBS washings, sections were incubated with
the appropriate peroxidase-conjugated secondary antibodies.
After PBS washings, sections were developed with power
diaminobenzidine (DAB) (Immunologic) as a chromogen and
dehydrated and then slides were mounted with permount.
Results
Biomatrix characterization
Table 1 reviews the biochemical characteristics of the
biomatrices. The biomatrices were highly porous (pores
ranging 100–150mm; Fig. 1B) and successfully crosslinked as
evidenced by a decrease of amine group content of 38% and
56% for the crosslinked and heparinized biomatrices, re-
spectively. Heparinized biomatrices contained 18wt% of
heparin. Estimates from Western blot analyses revealed a
total amount of 0.4 mg bound GFs per milligram of scaffold
(VEGF 30%, FGF-2 27%, HB-EGF 42%).
The method used to bind GFs involved incubation of
FGF-2 after which VEGF and HB-EGF were added. This
method was found to be the most optimal method resulting
in binding approximately equal amounts of each GF, as HB-
EGF was highly competitive in binding heparin, especially
with respect to FGF-2. Other incubation methods, namely
simultaneous or proportional incubation, were not adequate.
The GF incubation concentrations were selected based upon
a previous work.11
Clinical observations
All animals recovered satisfactory from the initial sur-
gery (Fig. 1C) and survived without any sign of difficulty
in urinating or urinary retention. No strictures or ure-
throcutaneous fistula were observed in the group without
GFs (COLX) (Fig. 1D). The retrograde urethrogram of the
group without GFs showed normal caliber of the urethra at
all time points (Fig. 2A, C, E, F). Only two rabbits developed
small diverticula at 12 weeks. In the group with heparin and
GF-supplemented tubular biomatrices (COLX-Hep-GF) (Fig.
2B, D, F, H), all four rabbits showed relative narrowing of the
urethra at 2 weeks (Fig. 2B). In 11 of 12 rabbits receiving
COLX-Hep-GF tubular biomatrices (4, 12, and 24 weeks
postrepair groups), a diverticula of the urethra was ob-
served. One rabbit in this group showed a urethrocutaneous
fistula at 24 weeks (Fig. 2D). Macroscopic inspection con-
firmed these findings on urethrography.
Histological examination
The microscopical evaluation of urethral regeneration was
semiquantified and is summarized in Table 2. Representative
images are shown in Figures 3 and 4.
Two weeks evaluation. Granulocytes infiltrated the bio-
matrix, regardless of the biomatrix modification procedure
with GFs (Fig. 3A, B). More giant cells were observed in the
COLX-Hep-GF biomatrix. Neovascularization (CD31) was
observed at the rim of the biomatrix (Fig. 4A, B). The COLX-
Hep-GF biomatrix revealed purple-pink-colored matrix
structures on hematoxylin and eosin staining, indicative of
the presence of immobilized heparin. Despite precautions to
completely remove the native urothelium, some remnants
with smooth muscle cells underneath could be localized at
the dorsal site of the urethra in almost all rabbits. This was
confirmed by staining for desmin. Tissue regeneration was
observed in the biomatrix as well as below the biomatrix. In
this manner, the tubular construct also facilitated urethral
reconstruction by functioning as an onlay.
Four weeks evaluation. The amount of granulocytes
decreased in the COLX biomatrix but not in the COLX-Hep-
GF biomatrix (Fig. 3C, D). More fibroblast-like cells and
newly formed ECM were present in the COLX-Hep-GF
biomatrix compared with COLX. As in the latter, still empty
porous biomatrix structures could be found. The number of
giant cells, present at the periphery of the biomatrix, was
higher in COLX-Hep-GF compared with COLX. Also, neo-
vascularization was increased in the COLX-Hep-GF group,
Table 2. Summary of Cellular Features,
Listing Urothelium-Related Topics Separately
Weeks of implantation
2 weeks 4 weeks 12 weeks 24 weeks
COLX
Granulocytes þþ þ  
Lymphocytes sp  sp 
Giant cells sp þþ sp 
Macrophages  sp  sp
Neovascularization   þþ þþ
Biomatrix remnants þþ þþ  
ECM production  þ þþ þþ
Fibroblast-like cells  þ þþ þþ
Urothelium   þþ þþ
Number of glands   þþ þ/þþ
Glandular hyperplasia    þ
Budding    þ
COLX-Hep-GF
Granulocytes þþ þþ  
Lymphocytes sp þ þ sp/
Giant cells  þþ þ 
Macrophages  þ  sp
Neovascularization  þ/þþ þþ þþ
Biomatrix remnants þþ þþ þ 
ECM production þ þ/þþ þþ þþ
Fibroblast-like cells þ þ/þþ þþ þþ
Urothelium  þ/þþ þþ þþ
Number of glands  þþ þþ þ
Glandular hyperplasia  þ þ þ
Budding  þ þþ þ
Scoring was done by two independent couples. Events were
scored ranging from sporadic (sp) to abundant (þþ).
COLX, crosslinked collagen biomatrix; ECM, extracellular matrix;
COLX-Hep-GF, heparinized collagen biomatrices supplemented
with growth factors; , not present.
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based upon more CD31-positive vessels. Newly formed and
organized urothelium was cytokeratin positive and found to
be increased in the COLX-Hep-GF biomatrix, though only
sporadically present in the COLX biomatrix (Fig. 4C, D).
Twelve weeks evaluation. The cellular infiltration of
granulocytes was reduced in all biomatrices (Fig. 3E, F).
More lymphocytes and macrophages were present in the
COLX-Hep-GF biomatrix in comparison to the COLX bio-
matrix. In both types of biomatrices, the level of interstitial
ECM production and fibroblasts was increased in compari-
son to the situation at 4 weeks after implantation. In
the COLX group, the scaffold was completely replaced by
urethra-like tissue. In contrast, biomatrix remnants were still
observed in the COLX-Hep-GF biomatrix. In both bioma-
trices, urothelium and capillaries became more evident.
Neovascularization (CD31 staining) was comparable be-
tween both groups. A profound increase of glands, which
were also positive for cytokeratin, and fusion of these was
present in the COLX-HEP-GF in comparison to the COLX
biomatrix (Fig. 4E, F).
Twenty-four weeks evaluation. The inflammatory re-
sponse was additionally decreased. Both types of biomatrices
were replaced by urethra-like structures; a normal transitional
layer of epithelium was surrounded by vascularized tissue
(Fig. 3G, H). COLX-Hep-GF biomatrices were almost fully
degraded. A decrease in the number of glands was seen in
both groups in comparison with 12 weeks after implantation
(Table 2). Fusion of these, or budding, was increased in COLX
and decreased in COLX-Hep-GF. Nomuscle cells were visible
in the new tissue of both groups. A clear transition could be
made between old and new tissue, as the latter was recog-
nizable by underlying desmin-positive muscle (Fig. 4G, H).
Both old and new tissues had cytokeratin-positive epithelium
that was comparable to one another.
Discussion
Literature data suggest that cell seeding is critical to re-
generate urethral tissue and avoid stricture formation when
collagen grafts are used for urogenital reconstructions.6–9
Cell seeding necessitates tissue harvesting for the cellular
components, causing an increase in morbidity, and—more
importantly—comes with a complex, labor-intensive, and
time-consuming procedure. It would be advantageous to de-
velop an acellular biomatrix with a high capacity to regenerate
urethral tissues. A tubular biomatrix may be a suitable alter-
native for patients in need for a total urethral reconstruction,
such as patients with severe hypospadias or long urethral
strictures. In a previous study,4 we investigated an onlay
urethral procedure in a rabbit model with an unmodified,
acellular collagen-based biomatrix, compared it with an SIS,
and observed comparable regeneration of the urethra. En-
couraged by the results of that study, we decided to develop
novel, molecularly defined tubular biomatrices (containing
pores of about 100–150mm) substitutedwith three GFs (VEGF,
FGF-2, and HB-EGF), by coupling with covalently attached
heparin. These GFs are known to have a stimulatory effect on
various cellular processes including cell influx, angiogenesis,
and proliferation/differentiation, thus improving the regen-
erative capacity of the construct. It is known from literature
that epidermal GF plays a key role in urothelial regeneration,10
whereas FGF-2 and VEGF are involved in angiogenesis and
blood vessel maturation.11 In an in vitro pilot study, optimal
proliferation of urothelial cells (SCaBER) was seen by the sole
use of EGF (unpublished results).
We evaluated the regenerative capacity of these bioma-
trices without and with GFs (COLX and COLX-Hep-GF) in a
rabbit model by replacing 1 cm urethra, a critical-sized de-
fect,17 and compared the outcome at 2, 4, 12, and 24 weeks
after implantation. Successful regeneration without urethral
occlusion was achieved with the tubular COLX biomatrix.
Retrograde urethrogram analysis indicated normal caliber of
the urethra at all time points, underscoring its effectiveness.
Histology of the COLX biomatrix indicated a mild cellular
response, with the formation of normal urothelium and
capillaries within 24 weeks. For the COLX-Hep-GF biomatrix,
a profound effect on tissue regeneration was observed, in-
cluding an increase in ECM, urothelium, capillaries, glands,
and the number of granulocytes, lymphocytes, and macro-
phages. Sievert et al. already showed the importance of the
time-dependent changes in GF expression during regenera-
tion. Through the addition of GF to the biomatrix we mimic a
depot of GFs in a slow release system, leading to faster ure-
thral regeneration.18 Additionally, genetically engineered
urethral grafts expressing human VEGF significantly induced
neovascularization in the urethral wall.19 VEGF attracts en-
dothelial cells and the combination with FGF-2 has proven to
further enhance an early and well-developed vasculature.11
Nevertheless, although we assumed that the addition of GF
would facilitate and quicken urethral regeneration, urethro-
gram analysis of the COLX-Hep-GF group indicated a relative
narrowing of the replaced urethral segment at 2 weeks and
dilatation (diverticula) at 12 and 24 weeks. The histological
analyses suggest that dilatation is caused by an increase in
urothelium ingrowth in comparison to the unmodified bio-
matrix. The fact that FGF-2 and HB-EGF promote epithelial
FIG. 3. Histology of explanted biomatrices (hematoxylin and eosin staining). The left column displays results of the COLX
group; the right column displays results of the COLX-Hep-GF group. The hematoxylin and eosin staining at the bottom
shows the native tissue, with urothelium (black arrowhead) and the underlying smooth muscle (red arrowhead). (I) At week
2 after implantation, granulocytes had infiltrated the biomatrix (white arrowhead) (A, B). After 4 weeks, more newly formed
extracellular matrix (white arrow) was present in the COLX-Hep-GF biomatrix in comparison to the COLX biomatrix.
Remnants of the biomatrix (red arrow) were found in the neourethra in both groups (C, D). An increase of glands and an
increase in fusion (black arrow) of these glands were observed in the COLX-Hep-GF in comparison to the normal COLX
biomatrix at 12 weeks (E, F). Both types of biomatrices were replaced by urethra-like structures at 24 weeks. The neourethra
was only distinguishable from normal urethra by the fact that there were no muscle cells visible in the replacement tissue (G,
H). Black arrowheads show the border between native tissue and new regenerated tissue. Bars represent 1mm and 200 mm
within the inset. L: lumen. Color images available online at www.liebertonline.com/ten.
‰
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FIG. 4. Immunohistochemical analysis of blood vessels, urothelium, glands, and muscle cells in biomatrices. Neovascu-
larization (CD31 staining, blue arrowheads) in the biomatrix at 2 weeks after implantation (A, B). Newly formed urothelium
at 4 weeks after implantation (cytokeratin staining, black arrowheads), indicating a more organized urothelial layer in the
COLX-Hep-GF biomatrix in comparison to the COLX biomatrix (C, D). This new urothelium also resulted in an increase and
fusion of glands (black arrows) in the COLX-Hep-GF group in comparison to the normal COLX biomatrix (E, F, H). Both
types of biomatrices were replaced by urethra-like structures and only distinguishable from normal urethra by the lack of
smooth muscle cells in the newly formed tissue compared with original tissue (desmin staining, red arrowhead) (G). Bars
represent 1mm and 200 mm within the inset. L: lumen; red arrow: biomatrix remnants; white arrow: newly formed extra-
cellular matrix. Color images available online at www.liebertonline.com/ten.
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migration and reepithelialization in wound healing20,21 may
explain the urothelium migration and proliferation into the
wall of the biomatrix. This may be prevented by binding HB-
EGF only to the luminal side of the biomatrix wall. Epithelial
glands that were formed inside the construct seemed to fuse
into lacunae. This may explain the decrease in the absolute
number of glands after 24 weeks. In a human setting, periur-
ethral glands are of eminent importance; for example, glands
of Littre´ are needed for a normal secretion of the seminal
substance. Additionally, these glands are known to form, at
times, small diverticula known as lacunae of Morgagni.22,23
These results implicate that the tubular collagen COLX bio-
matrix is capable of and succeeds in the regeneration of
functional urethra-like tissue. The tubular COLX biomatrix
had better functional outcome in comparison to tubular
COLX-hep-GF biomatrix. GFs substantially improved ‘‘mo-
lecular’’ features of healing but failed to be superior in func-
tional outcome (narrowed urethras, urethras with diverticula,
and one fistula). The present study shows that caution should
be regarded with respect to the use of GFs, and that bioma-
trices without GFs do not have to be inferior to those with GFs.
In binding GFs, the biomatrices were first bound with the
glycosaminoglycan heparin. After 12 weeks, COLX-Hep-GF
biomatrix remnants were still present, whereas the plain col-
lagen biomatrix was fully degraded. This may be explained
by the fact that the incorporated heparin is highly negatively
charged because of the presence of sulfate and carboxylic
groups, which may protect collagen from proteolysis, and has
an inhibitory effect on the macrophage adhesion, thus de-
laying matrix degradation.24
Even though every precaution was taken to completely
remove the native urothelium during surgery, this was
extraordinarily difficult without causing excessive bleed-
ing from the corpus cavernosa. As a result, some native
urothelium was left at the dorsal site of the urethra. These
urothelial remnants tend to induce tissue regeneration at the
outside of the tubular construct, probably creating a new lu-
men through which urine was voided. As a result, the tubular
construct most likely functioned as an onlay sometimes, thus
implicating that at least small parts of the biomatrix could be
lost because of voiding during (bio)matrix remodeling. The
use of running sutures at the anastomoses or a temporary
transurethral catheter may solve this problem.
Several investigators studied onlay urethroplasty in a
rabbit model.3–5 Single-layer SIS appears to be inferior to
spontaneous urethral regeneration, possibly because SIS
impedes smooth muscle cell regeneration, although results
have been variable.3,7 The conflicting results might be the
consequence of dissimilarities in different SIS batches.25
Similar to SIS, our constructs did not support smooth
muscle cell ingrowth (smoothmuscle actin). This is in contrast
with results obtained with a decellularized tubularized con-
struct created from SIS where complete regeneration of all
urethral layers was reported as early as 12 weeks after urethra
repair.3 However, the clinical importance and relevance of
muscular cell ingrowth in a urethra is not clear. Urethroplasty
with SIS resulted in fibrotic tissue covered by urethral mucosa
without muscle cells at the site of SIS implantation.26 Animal
studies have indicated that the urethra is capable of complete
regeneration over a 15mm defect area when only the ventral
wall of the urethra is excised.7 However, a circumferential
defect as used here does not heal spontaneously and this
would imply that severe scarring may occur. Previous studies
have shown that with an acellular tubularized construct the
maximum defect distance that can be supported by normal
tissue regeneration is 0.5 cm, albeit that the longest time pe-
riod studied was only 4 weeks.17
Collectively, in the present study, the repair of a 1 cm
defect with collagen-based tubular biomatrices resulted in
excellent regeneration of the urethra without urethral oc-
clusion. In the future, long-term outcome of such matrices
has to be studied. The inclusion of a support, for example, a
polymer, may help to prevent voiding of urine alongside
instead of through the construct.
Conclusion
Tubular, molecularly defined collagen biomatrices are suc-
cessful in repairing urethral lesions of 1 cm in a rabbit model.
The results with these developed biomatrices are promising,
but further studies aimed at fine-tuning the effect of bound
GFs must be performed, particularly to prevent (initial) ex-
cessive cell proliferation and to induce ingrowth of smooth
muscle. Additionally, a composite construct may facilitate fu-
ture use of longer tubular segments in urethral reconstruction.
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